(RS)-4,5,6,7-Tetrahydrobenzothiophen-2-yl-[3-[5-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]-1-piperidyl]methanone

ID: ALA4793092

Chembl Id: CHEMBL4793092

PubChem CID: 162671029

Max Phase: Preclinical

Molecular Formula: C20H20F3N5OS

Molecular Weight: 435.48

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(c1cc2c(s1)CCCC2)N1CCCC(c2cc(C(F)(F)F)nc3ncnn23)C1

Standard InChI:  InChI=1S/C20H20F3N5OS/c21-20(22,23)17-9-14(28-19(26-17)24-11-25-28)13-5-3-7-27(10-13)18(29)16-8-12-4-1-2-6-15(12)30-16/h8-9,11,13H,1-7,10H2

Standard InChI Key:  CFGPEAHYFLTJPO-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4793092

    ---

Associated Targets(Human)

PDE2A Tclin Phosphodiesterase 2A (1799 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pde10a cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (1396 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 435.48Molecular Weight (Monoisotopic): 435.1341AlogP: 4.10#Rotatable Bonds: 2
Polar Surface Area: 63.39Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.43CX LogD: 4.43
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.61Np Likeness Score: -2.17

References

1. Tresadern G,Velter I,Trabanco AA,Van den Keybus F,Macdonald GJ,Somers MVF,Vanhoof G,Leonard PM,Lamers MBAC,Van Roosbroeck YEM,Buijnsters PJJA.  (2020)  [1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2A Inhibitors: Structure and Free-Energy Perturbation-Guided Exploration.,  63  (21.0): [PMID:33105987] [10.1021/acs.jmedchem.0c01272]

Source